Table 5.
No. (%) Total (n = 174) | Survivor (n = 165) | Non-Survivor (n = 9) | P value | |
---|---|---|---|---|
Age, % | <0.001 | |||
≥65y | 20 (11.5) | 16 (9.7) | 4 (44.4) | |
45≤age<65 | 60 (34.5) | 55 (33.3) | 5 (55.6) | |
<45y | 94 (54.0) | 94 (57.0) | 0 (0.0) | |
Gender, % | ||||
Male | 88 (52.3) | 84 (50.9) | 4 (44.4) | 0.706 |
Female | 86 (47.7) | 81 (49.1) | 5 (55.6) | |
Symptoms | ||||
Fever, % | 116 (66.7) | 108 (65.5) | 8 (88.9) | 0.148 |
Cough, % | 147 (84.5) | 140 (84.8) | 7 (77.8) | 0.608 |
Myalgia, % | 16 (9.2) | 16 (9.7) | 0 (0.0) | 0.328 |
Fatigue, % | 74 (42.5) | 72 (43.6) | 2 (22.2) | 0.207 |
Headache, % | 23 (13.2) | 23 (13.9) | 0 (0.0) | 0.231 |
Diarrhoea, % | 43 (24.7) | 41 (24.8) | 2 (22.2) | 0.859 |
Abdominal pain, % | 3 (1.7) | 3 (1.8) | 0 (0.0) | 0.684 |
Shortness of breath, % | 53 (30.5) | 50 (30.3) | 3 (33.3) | 0.848 |
Notes: P values indicate differences between survivor and non-survivor of COVID-19 patients without underlying diseases. P< 0.05 was considered statistically significant (marked in bold).
Abbreviation: COVID-19, Coronavirus disease 2019.